Results 21 to 30 of about 71,273 (273)

Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma [PDF]

open access: yes, 2010
Background The Sonic hedgehog (Shh) signaling pathway is critical for cell growth and differentiation. Impairment of this pathway can result in both birth defects and cancer.
Afzal, Mohammad   +6 more
core   +5 more sources

Medulloblastomas

open access: yesNeurosurgery Clinics of North America, 1990
It is obvious that the past decade has witnessed considerable progress in the management of children with medulloblastoma. Better surgical technique has led to more aggressive surgery with less morbidity. The use of staging has led to reduction in radiation therapy doses in some patients and will, it is hoped, lead to better neuropsychological outcome.
L N, Sutton, R J, Packer, L, Schut
openaire   +2 more sources

Metastatic Medulloblastoma [PDF]

open access: yesCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1974
SUMMARY:The incidence of metastatic medulloblastoma is probably greater than the thirteen documented patients. Case reports of metastatic medulloblastoma must be carefully analysed. We have added two cases which conform to Weiss’ criteria for metastatic disease. The direction and factors influencing spread have been discussed.
D, Parkinson, R T, Ross, C B, Shields
openaire   +2 more sources

Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma

open access: yesBMC Cancer, 2019
Background MYC amplification or overexpression is common in Group 3 medulloblastoma and is associated with the worst prognosis. Recently, protein arginine methyl transferase (PRMT) 5 expression has been closely associated with aberrant MYC function in ...
Nagendra K. Chaturvedi   +11 more
doaj   +1 more source

Delta-catenin attenuates medulloblastoma cell invasion by targeting EMT pathway

open access: yesFrontiers in Genetics, 2022
Background: Medulloblastoma is the most common pediatric malignant tumor in central nervous system. Although its prognosis has been improved enormously by the combination treatments with surgery, radiotherapy, and chemotherapy, it still could progress ...
Yuanjun Hu   +14 more
doaj   +1 more source

Molecular subgroups of adult medulloblastoma: a long-term single-institution study [PDF]

open access: yes, 2016
Background Recent transcriptomic approaches have demonstrated that there are at least 4 distinct subgroups in medulloblastoma (MB); however, survival studies of molecular subgroups in adult MB have been inconclusive because of small sample sizes. The aim
Ai, Lin   +13 more
core   +1 more source

Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era

open access: yesFrontiers in Oncology, 2020
Medulloblastoma is the most common malignant brain tumor in children. In addition to sporadic cases, medulloblastoma may occur in association with cancer predisposition syndromes.
Roberto Carta   +18 more
doaj   +1 more source

Neurodegeneration-associated protein VAPB regulates proliferation in medulloblastoma

open access: yesScientific Reports, 2023
VAMP (Vesicle-associated membrane protein)-associated protein B and C (VAPB) has been widely studied in neurodegenerative diseases such as ALS, but little is known about its role in cancer.
Amanda Faria Assoni   +11 more
doaj   +1 more source

Numb Isoforms Deregulation in Medulloblastoma and Role of p66 Isoform in Cancer and Neural Stem Cells [PDF]

open access: yes, 2018
Numb is an intracellular protein with multiple functions. The two prevalent isoforms, Numb p66 and Numb p72, are regulators of differentiation and proliferation in neuronal development.
Agnese Po   +13 more
core   +9 more sources

Disseminated medulloblastoma in a child with germline BRCA2 6174delT mutation and without Fanconi anemia

open access: yesFrontiers in Oncology, 2015
Medulloblastoma, the most common malignant brain tumor in children, occurs with increased frequency in individuals with Fanconi anemia who have biallelic germline mutations in BRCA2.
Jingying eXu   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy